NSE: COHANCE · Healthcare
Cohance Lifesciences share price
NSE close 29 Oct 2026
Cohance Lifesciences share price chart, one year
Key figures
- 1M return
- +5.12%
- from 29 Sep 2026 close
- 3M return
- +11.60%
- from 29 Jul 2026 close
- 6M return
- +2.95%
- from 29 Apr 2026 close
- This year
- −8.94%
- from 31 Dec 2025 close
- 1Y return
- −38.79%
- from 29 Oct 2025 close
- 52-week closing high
- Rs 778.95
- 30 Oct 2025; latest close −38.21% from it
- 52-week closing low
- Rs 279.90
- 6 Mar 2026; latest close +71.97% from it
- Average turnover
- Rs 36.72 cr
- a session, 20 sessions to 28 Oct 2026
- Average delivery
- 44.8%
- of shares traded, weighted by volume
- Volume against its norm
- 1.9x
- 14,95,780 shares on 29 Oct 2026, against 8,03,369 a session
- Largest move, 3 months
- +6.42%
- on 20 Aug 2026
Against the Nifty 50, to 29 Oct 2026
| Period | COHANCE | Nifty 50 | Difference, points |
|---|---|---|---|
| 1M | +5.12% | +0.97% | +4.15 |
| 3M | +11.60% | −5.42% | +17.02 |
| This year | −8.94% | −12.22% | +3.28 |
Cohance Lifesciences share price: questions
What is the share price of Cohance Lifesciences?
Cohance Lifesciences closed at Rs 481.35 on NSE on 29 October 2026, +1.11% on the day. Its NSE symbol is COHANCE.
What is the 52-week high of Cohance Lifesciences?
The 52-week closing high of Cohance Lifesciences is Rs 778.95, set on 30 October 2025. The latest close is −38.21% from it. This is the highest close restated for splits and bonuses, not the intraday high.
What is the 52-week low of Cohance Lifesciences?
The 52-week closing low of Cohance Lifesciences is Rs 279.90, set on 6 March 2026. The latest close is +71.97% from it. This is the lowest close restated for splits and bonuses, not the intraday low.
How has Cohance Lifesciences performed against the Nifty 50 this year?
From the last close of 2025 to 29 October 2026, Cohance Lifesciences returned −8.94% and the Nifty 50 −12.22%: 3.28 percentage points ahead of the index. These are price returns, without dividends.
What is the return of Cohance Lifesciences over the last year?
To the NSE close on 29 October 2026, Cohance Lifesciences returned +5.12% over one month, +2.95% over six months, −38.79% over one year. These are price returns adjusted for splits and bonuses, without dividends.
How much of Cohance Lifesciences is traded on NSE on a typical day?
Over the 20 sessions to 28 October 2026, Cohance Lifesciences averaged Rs 36.72 crore of turnover and 8,03,369 shares a session, with 44.8% of shares delivered.
Where these figures come from
Facts from NSE’s files and Oquilia’s own data, not investment advice.
- Prices are NSE closing prices from the daily bhavcopy. Returns chain each session's close against the previous close, adjusted for splits, bonuses, rights and demergers from NSE's corporate-action file, as on Oquilia's Market Movers pages; they exclude dividends.
- Turnover, volume and delivery average the 20 sessions before 29 Oct 2026 (29 Sep 2026 to 28 Oct 2026); delivery is weighted by volume.
- Bulk and block deals: NSE publishes only the latest session's files, and Oquilia has stored them since 27 Oct 2026, so the 30-day window is complete only from then.
- NSE full bhavcopy, 2026-10-29 (close, volume, turnover, delivery)
- NSE index closes, 2026-10-29 (Nifty 50)
Figures as of the NSE close on 29 October 2026. See also all Nifty 500 share prices and market movers.